Psoriasis

Lancet

Volumn 350, Issue 9074, 1997, Pages 349-353

  Stern, Robert S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT;

CELL MIGRATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; PSORIASIS; SHORT SURVEY; SYMPTOM;

EID: 0030755596     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)05257-4     Document Type: Review

References (32)

1. Stern RS, Wu J. Psoriasis. In: Arndt KA, Le Boit PL, Robinson JK, Wintroub BU, eds. Cutaneous medicine and surgery. Philadelphia:WB Saunders, 1996: 295-331.
2. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol. 105:1995;89-94S.
3. Braverman IM, Sibley BA Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol. 78:1982;12-17.
4. Melski JW, Bernhard JD, Stern RS The Koebner (isomorphic) response in psoriasis: association with early age of onset and multiple previous therapies. Arch Dermatol. 119:1983;655-659.
5. Tefler NR, Chalmers RJG, Whale Ket al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 128:1992;39-42.
6. Leung DYM, Travers JB, Giorno Ret al. Evidence for streptococcal superantignen-driven process in acute guttate psoriasis. J Clin Invest. 96:1995;2106-2112.
7. Boyd AS, Menter A Erythrodermic psoriasis. J Am Acad Dermatol. 21:1989;1985-1991.
8. Baker H Corticosteroids and pustular psoriasis. Br J Dermatol. 12:1976;83-88.
9. Roujeau JC, Bioulac-Sage P, Bourseau Cet al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 127:1991;1333-1338.
10. Alonso JCTA, Perez AR, Castrillo JMAet al. Psoriatic arthritis: a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 80:1991;245-250.
11. Naldi L, Parazzini F, Peli Let al. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol. 134:1996;101-106.
12. Henseler T, Christophers E Disease concomitance in psoriasis. J Am Acad Dermatol. 32:1995;982-986.
13. Henseler T, Christophers E Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 13:1985;450-456.
14. Elder JT, Nair RP, Guo SWet al. The genetics of psoriasis. Arch Dermatol. 130:1994;216-224.
15. Tomfohrde J, Silverman A, Barnes Ret al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science. 264:1994;1141-1145.
16. Molin L, Cutler TP, Helander Let al. Comparative efficacy of calcipotriol (MC 903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicenter study. Calcipotriol Study Group. Br J Dermatol. 136:1997;89-93.
17. Meola T Jr., Soter NA, Lim HW Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? Arch Dermatol. 127:1991;1708-1713.
18. Binderup L, Latini S, Binderup Eet al. 20-epi vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol. 42:1991;1569-1575.
19. Schaefer H, Farber EM, Goldberg Let al. Limited application period of dithranol in psoriasis. Br J Dermatol. 102:1980;571-573.
20. Stern RS The benefits, costs and risks of topical tar preparations in the treatment of psoriasis: considerations of cost effectiveness. Ann Acad Med Singapore. 17:1988;473-476.
21. Snellman E Comparison of the antipsoriatic efficacy of heliotherapy and ultraviolet B: a cross over study. Photodermatol Photoimmunol Photomed. 9:1992;83-85.
22. Krueger JG, Wolfe JT, Nabeya RTet al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med. 182:1995;2057-2068.
23. Parrish JA, Jaenicke KF Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 76:1981;359-362.
24. Stern RS, Armstrong RB, Anderson TFet al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol. 15:1986;546-552.
25. Parrish JA, Fitzpatrick TB, Tanenbaum Let al. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 291:1974;1207-1211.
26. Stern RS, Laird N, Melski Jet al. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med. 310:1984;1156-1161.
27. Stern RS, Nichols KT, Väkevä LH Malignant melanoma in patients treated for psoraisis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med. 336:1997;1041-1045.
28. Zachariae H, Sogaard H, Heickendorff L Methotrexate-induced liver cirrhosis. A follow-up. Dermatology. 192:1996;343-346.
29. Kaplan RP, Russell DH, Lowe NJ Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses. J Am Acad Dermatol. 8:1983;95-102.
30. Stern RS, Fitzgerald E, Ellis CNet al. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. J Am Acad Dermatol. 33:1995;44-52.
31. Ellis CN, Fradin MS, Messana JMet al. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med. 324:1991;277-284.
32. Gottlieb SL, Gilleaudeau P, Johnson Ret al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1:1995;442-447.